|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/573 | |
| A61K 31/55 | |||
| A61K 9/12 | |||
| A61P 11/02 |
| (11) | Number of the document | 2647380 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11845222.6 |
| Date of filing the European patent application | 2011-11-18 | |
| (97) | Date of publication of the European application | 2013-10-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-02-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2011/008826 |
| Date | 2011-11-18 |
| (87) | Number | WO 2012/074231 |
| Date | 2012-06-07 |
| (30) | Number | Date | Country code |
| 20100119632 | 2010-11-29 | KR |
| (72) |
LEE, Sang-Yong, KR
LEE, Geun-Hyeog, KR
CHOI, Byong-Sun, KR
RYU, Jong-Hyeon, KR
PARK, Jin-Ha, KR
O, Mi-Jin, KR
|
| (73) |
Hanlim Pharmaceutical Co., Ltd.,
1007 Yubang-dong Cheoin-gu Yongin-si, Gyeonggi-do 449-935,
KR
|
| (54) | PHARMACEUTICAL COMPOSITION INCLUDING MOMETASONE FUROATE AND AZELASTINE HYDROCHLORIDE FOR NASAL ADMINISTRATION |
| PHARMACEUTICAL COMPOSITION INCLUDING MOMETASONE FUROATE AND AZELASTINE HYDROCHLORIDE FOR NASAL ADMINISTRATION |